Pregled bibliografske jedinice broj: 1226316
Availability of oncological drugs in Croatia and consumption in the last decade
Availability of oncological drugs in Croatia and consumption in the last decade // Farmaca 2022, 52:3
Pula, Hrvatska, 2022. str. 57-57 (pozvano predavanje, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 1226316 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Availability of oncological drugs in Croatia and
consumption in the last decade
Autori
Draganić, Pero
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Farmaca 2022, 52:3
/ - , 2022, 57-57
Skup
10th Adriatic and 7th Croatian congress of pharmacoeconomics and outcomes research
Mjesto i datum
Pula, Hrvatska, 02.06.2022. - 04.06.2022
Vrsta sudjelovanja
Pozvano predavanje
Vrsta recenzije
Domaća recenzija
Ključne riječi
oncological drugs, Croatia, consumption
Sažetak
According to the main theme of this Congress „Access to health in Central and Eastern Europe” and subtheme „Health economic aspects of Cancer Care in CEE countries” we have examined the consumption of the oncology related drugs in Croatia. Considering Europe's Beating Cancer Plan, this gives an extensive insight into cancer drug utilization, as an economic and a public health issue, thus detecting the possible obstacles. Our target is to investigate the utilization trends of cancer drugs in Croatia during the period 2011 - 2020, thus focusing on the Antineoplastic Agents (L01) pharmacological/therapeutic ATC group. During the period 2011-2020, the utilization of cancer drug therapy increased continuously and significantly. The biggest expenditure is noticed in the Other Antineoplastic Agents (L01X) group, which includes the most of new, efficient, specific and, after all, expensive drugs.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
